203 related articles for article (PubMed ID: 21924076)
1. [Effect of atorvastatin on advanced glycation end products induced monocyte chemoattractant protein-1 expression in cultured human endothelial cells].
Xu SH; Wang KF; Xu CS; Xie LD
Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Jun; 39(6):512-7. PubMed ID: 21924076
[TBL] [Abstract][Full Text] [Related]
2. [Influence of atorvastatin on the expression of monocyte chemoattractant protein-1 in peritoneal mesothelial cells by high glucose].
Li ZM; Ma JF; Wang LN
Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(38):2677-80. PubMed ID: 18167242
[TBL] [Abstract][Full Text] [Related]
3. Atorvastatin decreases C-reactive protein-induced inflammatory response in pulmonary artery smooth muscle cells by inhibiting nuclear factor-kappaB pathway.
Li J; Li JJ; He JG; Nan JL; Guo YL; Xiong CM
Cardiovasc Ther; 2010; 28(1):8-14. PubMed ID: 20074254
[TBL] [Abstract][Full Text] [Related]
4. 15-Deoxy-Δ(12,14)-prostaglandin J(2) modulates lipopolysaccharide-induced chemokine expression by blocking nuclear factor-κB activation via peroxisome proliferator activated receptor-γ-independent mechanism in renal tubular epithelial cells.
Lu Y; Zhou Q; Zhong F; Guo S; Hao X; Li C; Wang W; Chen N
Nephron Exp Nephrol; 2013; 123(1-2):1-10. PubMed ID: 23887394
[TBL] [Abstract][Full Text] [Related]
5. Atorvastatin prevents peroxisome proliferator-activated receptor gamma coactivator-1 (PGC-1) downregulation in lipopolysaccharide-stimulated H9c2 cells.
Planavila A; Sánchez RM; Merlos M; Laguna JC; Vázquez-Carrera M
Biochim Biophys Acta; 2005 Sep; 1736(2):120-7. PubMed ID: 16139565
[TBL] [Abstract][Full Text] [Related]
6. [Advanced glycation end products stimulate human endothelial cells to produce monocyte chemoattractant protein-1].
Guo ZJ; Hou FF; Liang M; Wang L; Zhang X; Liu ZQ
Zhonghua Yi Xue Za Zhi; 2003 Jun; 83(12):1075-9. PubMed ID: 12899782
[TBL] [Abstract][Full Text] [Related]
7. [Effects of PPAR-gamma agonist rosiglitazone on MMP-9 and TIMP-1 expression of monocyte-derived macrophages isolated from patients with acute coronary syndrome].
Luo YM; Wan XH; Jiang DQ; Kuang WY; Guo HB; Chen ZX; Wang HJ; Xie LH; Duan W
Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Aug; 37(8):739-45. PubMed ID: 20021931
[TBL] [Abstract][Full Text] [Related]
8. Activation of peroxisome proliferator-activated receptor gamma inhibits TNF-alpha-mediated osteoclast differentiation in human peripheral monocytes in part via suppression of monocyte chemoattractant protein-1 expression.
Hounoki H; Sugiyama E; Mohamed SG; Shinoda K; Taki H; Abdel-Aziz HO; Maruyama M; Kobayashi M; Miyahara T
Bone; 2008 Apr; 42(4):765-74. PubMed ID: 18242157
[TBL] [Abstract][Full Text] [Related]
9. Telmisartan, an angiotensin II type 1 receptor blocker, inhibits advanced glycation end-product (AGE)-induced monocyte chemoattractant protein-1 expression in mesangial cells through downregulation of receptor for AGEs via peroxisome proliferator-activated receptor-gamma activation.
Matsui T; Yamagishi S; Ueda S; Nakamura K; Imaizumi T; Takeuchi M; Inoue H
J Int Med Res; 2007; 35(4):482-9. PubMed ID: 17697525
[TBL] [Abstract][Full Text] [Related]
10. Telmisartan inhibits the proinflammatory effects of homocysteine on human endothelial cells through activation of the peroxisome proliferator-activated receptor-δ pathway.
Xu S; Song H; Huang M; Wang K; Xu C; Xie L
Int J Mol Med; 2014 Sep; 34(3):828-34. PubMed ID: 24994548
[TBL] [Abstract][Full Text] [Related]
11. [Effects of citreoviridin on the expression of MCP-1 and ILs induced by TNF-alpha in vein endothelial cells].
Hou H; Jia Q; Zhou R; Li C; Yuan N; Yang M; Ding G
Wei Sheng Yan Jiu; 2012 Mar; 41(2):195-8, 203. PubMed ID: 22611924
[TBL] [Abstract][Full Text] [Related]
12. In vitro effects of atorvastatin on lipopolysaccharide-induced gene expression in endometriotic stromal cells.
Sharma I; Dhawan V; Mahajan N; Saha SC; Dhaliwal LK
Fertil Steril; 2010 Oct; 94(5):1639-46.e1. PubMed ID: 19944411
[TBL] [Abstract][Full Text] [Related]
13. [Atorvastatin inhibits scavenger receptor A and monocyte chemoattractant protein-1 expressions in foam cell].
Zhu GY; Zhu XL; Li RT; Liu TB; Shang DY; Zhang Y
Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Jul; 35(7):666-9. PubMed ID: 17961438
[TBL] [Abstract][Full Text] [Related]
14. Docosahexaenoic acid reduces linoleic acid induced monocyte chemoattractant protein-1 expression via PPARγ and nuclear factor-κB pathway in retinal pigment epithelial cells.
Fang IM; Yang CH; Yang CM
Mol Nutr Food Res; 2014 Oct; 58(10):2053-65. PubMed ID: 25044948
[TBL] [Abstract][Full Text] [Related]
15. [Effect of nuclear factor-kappaB on peroxisome proliferator activated receptor gamma expression in Ana-1 cells].
Xiao B; Wang JC; Wang GS; Ji FY; Xu J
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2009 Jan; 21(1):3-7. PubMed ID: 19141181
[TBL] [Abstract][Full Text] [Related]
16. Rosiglitazone, a Peroxisome Proliferator-Activated Receptor (PPAR)-γ Agonist, Attenuates Inflammation Via NF-κB Inhibition in Lipopolysaccharide-Induced Peritonitis.
Zhang YF; Zou XL; Wu J; Yu XQ; Yang X
Inflammation; 2015 Dec; 38(6):2105-15. PubMed ID: 26047949
[TBL] [Abstract][Full Text] [Related]
17. The peroxisome proliferator-activated receptor γ agonist pioglitazone prevents NF-κB activation in cisplatin nephrotoxicity through the reduction of p65 acetylation via the AMPK-SIRT1/p300 pathway.
Zhang J; Zhang Y; Xiao F; Liu Y; Wang J; Gao H; Rong S; Yao Y; Li J; Xu G
Biochem Pharmacol; 2016 Feb; 101():100-11. PubMed ID: 26673543
[TBL] [Abstract][Full Text] [Related]
18. Atorvastatin suppresses LPS-induced rapid upregulation of Toll-like receptor 4 and its signaling pathway in endothelial cells.
Wang Y; Zhang MX; Meng X; Liu FQ; Yu GS; Zhang C; Sun T; Wang XP; Li L; Wang YY; Ding SF; Yang JM; Zhang Y
Am J Physiol Heart Circ Physiol; 2011 May; 300(5):H1743-52. PubMed ID: 21317307
[TBL] [Abstract][Full Text] [Related]
19. Angiogenic response of advanced glycation end products (AGEs) involves PPARgamma.
Devi MS; Sudhakaran PR
Indian J Biochem Biophys; 2012 Feb; 49(1):18-24. PubMed ID: 22435140
[TBL] [Abstract][Full Text] [Related]
20. [Atorvastatin inhibits macrophage-derived foam cell formation by suppressing the activation of PPARγ and NF-κB pathway].
Cheng X; Liu X; Song L; He Y; Li X; Zhang H
Nan Fang Yi Ke Da Xue Xue Bao; 2014 Jun; 34(6):896-900. PubMed ID: 24968852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
